New therapy aims to boost medication adherence in early psychosis
NCT ID NCT06192602
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a 10-session program called AIM-AT, which uses acceptance-based techniques to help people with recent-onset psychosis better understand their illness and stick to their medication. The trial involves 126 participants in Hong Kong and tracks their medication adherence and attitudes over 12 months. The goal is to improve long-term disease control by supporting consistent treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY PSYCHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Integrated Community Centers for Mental Wellness
Hong Kong, New Territories, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can virtual reality help quiet paranoia in schizophrenia?
- Veterans helping veterans: Peer-Led program aims to prevent suicide in those with serious mental illness
- Can a smartphone help silence distressing voices? online self-help program tested for psychosis
- AI could spot psychosis risk before it strikes
- Which country handles mentally ill offenders better? a Head-to-Head study
- Brain and eye clues to emotion recognition in autism and psychosis